Intelligence Platform

Patents

Browse 822 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8449909

Abuse-deterrent drug formulations

Collegium Pharmaceutical, Inc. · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8435943

Protein stabilization formulations

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8435570

Nitrite formulations and their use as nitric oxide prodrugs

The Board of Regents of the University of Texas System · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431116

Norovirus vaccine formulations

Takeda Vaccines (Montana), Inc. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404638

Dimer VEGF antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394405

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394406

Once daily formulations of tetracyclines

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372877

Stabilized statin formulations

Cumberland Pharmaceuticals Inc. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372979

Process for the production of high-purity 2,4′-dimethyl-3-piperidino-propiophenone (tolper

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372800

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367638

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

GALECTIN THERAPEUTICS, INC. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8357676

Ansamycin formulations and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349355

Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the phar

Anika Therapeutics S.r.l. · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8350079

Treprostinil formulation

United Therapeutics Corporation · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349987

Adhesive formulations

Covidien LP · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349892

Solid formulations of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337815

Pulmonary surfactant formulations

Discovery Laboratories, Inc. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323634

Stable formulations of highly concentrated recombinant human albumin-human granulocyte col

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8303995

Nitrite formulations and their use as nitric oxide prodrugs

The Board of Regents of the University of Texas System · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298589

Nitrite formulations and their use as nitric oxide prodrugs

The Board of Regents of the University of Texas System · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298580

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298576

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8246984

Formulation of insoluble small molecule therapeutics in lipid-based carriers

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted